thio-Cl-IB-MECA

Known as: thio-2-chloro-N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2002-2011
01220022011

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
A3 adenosine receptor (A3AR) is recognized as a novel therapeutic target for ischemic injury; however, the mechanism underlying… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2009
2009
A new series of 2-aralkynyl-N(6)-methyl-MECAs 10-13 were synthesized and evaluated in radioligand binding studies and in a new Eu… (More)
Is this relevant?
2006
2006
Structural determinants of ligand efficacy in the human A(3) adenosine receptor (AR) were studied using pharmacophore and docking… (More)
Is this relevant?
2006
2006
The highly selective agonists of the A(3) adenosine receptor (AR), Cl-IB-MECA (2-chloro-N(6)-(3-iodobenzyl)-5'-N… (More)
Is this relevant?
2002
2002
Ligand recognition has been extensively explored in G protein-coupled A(1), A(2A), and A(2B) adenosine receptors but not in the A… (More)
Is this relevant?
2002
2002
The potent adenosine A(1) receptor agonists, N(6)-cyclopentyladenosine (CPA) and 2-chloro-N(6)-cyclopentyladenosine (CCPA), were… (More)
Is this relevant?